Is ZYME stock safe? | Glauxie AI

Q: Is ZYME stock safe?

Zymeworks Inc. (ZYME) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Kenneth H. Galbraith. Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include... Employees: 200,000.

Q: What are the risks of investing in ZYME?

Identify key risks of investing in ZYME — debt, competition, volatility, and sector headwinds.

Q: Is ZYME a good long-term investment?

Evaluate ZYME as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does ZYME have?

Review ZYME total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is ZYME stock safe?

🦉

Zymeworks Inc. (ZYME)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOKenneth H. Galbraith

Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of...

Key Executives

Name	Title
Bijal Desai	Senior Vice President of Finance
Diana Papove	Vice President of Corporate Communications
Kenneth H. Galbraith	Chairman of the Board, Chief Executive Officer & President
Kristin Stafford	Executive VP & CFO
Laura O'Connor	Senior VP & Chief Human Resources Officer
Lindsey Foulkes	SVP of Corporate Development & Strategy

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

ZYME Profile Financials

What are the risks of investing in ZYME? Is ZYME a good long-term investment? How much debt does ZYME have?